These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 1670616)

  • 21. Extrapyramidal side effects in chlorpromazine recipients: emergence according to benztropine prophylaxis.
    Swett C; Cole JO; Shapiro S; Slone D
    Arch Gen Psychiatry; 1977 Aug; 34(8):942-3. PubMed ID: 889418
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cyamemazine (Tercian
    Khouri C; Lepelley M; Villier C; Bougerol T; Mallaret M;
    Therapie; 2017 Jun; 72(3):345-350. PubMed ID: 27726885
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of antiparkinson agents in preventing antipsychotic-induced extrapyramidal symptoms.
    Murphy JE; Stewart RB
    Am J Hosp Pharm; 1979 May; 36(5):641-4. PubMed ID: 36755
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Possible predictors of neuroleptic-resistant schizophrenic relapse: influence of negative symptoms and acute extrapyramidal side effects.
    Kinon BJ; Kane JM; Chakos M; Munne R
    Psychopharmacol Bull; 1993; 29(3):365-9. PubMed ID: 7907184
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Testing basic visual functions in the evaluation of extrapyramidal side effects of antipsychotic agents].
    Kéri S; Antal A; Szekeres G; Szendi I; Kovács Z; Janka Z; Benedek G
    Orv Hetil; 1998 Feb; 139(5):235-8. PubMed ID: 9489377
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prophylactic antiparkinson drug use: I. Initial prophylaxis and prevention of extrapyramidal side effects.
    Lavin MR; Rifkin A
    J Clin Pharmacol; 1991 Aug; 31(8):763-8. PubMed ID: 1679062
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Iatrogenic extrapyramidal disorders].
    Ludin HP
    Schweiz Med Wochenschr; 1990 Jun; 120(23):855-8. PubMed ID: 1972812
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuroleptic associated extrapyramidal symptoms.
    Maurer I; Zierz S; Möller HJ; Jerusalem F
    Br J Psychiatry; 1995 Oct; 167(4):551-2. PubMed ID: 8829733
    [No Abstract]   [Full Text] [Related]  

  • 29. The clinical use of anticholinergic drugs as treatment for extrapyramidal side effects of neuroleptic drugs.
    McEvoy JP
    J Clin Psychopharmacol; 1983 Oct; 3(5):288-302. PubMed ID: 6138370
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Initial anticholinergic prophylaxis for neuroleptic-induced extrapyramidal syndromes.
    Keepers GA; Clappison VJ; Casey DE
    Arch Gen Psychiatry; 1983 Oct; 40(10):1113-7. PubMed ID: 6138011
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The prevalence of metoclopramide-induced tardive dyskinesia and acute extrapyramidal movement disorders.
    Ganzini L; Casey DE; Hoffman WF; McCall AL
    Arch Intern Med; 1993 Jun; 153(12):1469-75. PubMed ID: 8512437
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Motor and mental aspects of extrapyramidal syndromes.
    Casey DE
    Int Clin Psychopharmacol; 1995 Sep; 10 Suppl 3():105-14. PubMed ID: 8866772
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of piracetam on extrapyramidal side effects induced by neuroleptic drugs.
    Kabes J; Sikora J; Pisvejc J; Hanzlicek L; Skondia V
    Int Pharmacopsychiatry; 1982; 17(3):185-92. PubMed ID: 6128331
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuroleptic-induced extrapyramidal reactions: classification, description, and diagnosis.
    Tarsy D
    Clin Neuropharmacol; 1983; 6 Suppl 1():S9-26. PubMed ID: 6139168
    [No Abstract]   [Full Text] [Related]  

  • 35. Motor and mental aspects of acute extrapyramidal syndromes.
    Casey DE
    Acta Psychiatr Scand Suppl; 1994; 380():14-20. PubMed ID: 7914042
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anticholinergic anti-Parkinson medication for neuroleptic-induced extrapyramidal side effects.
    Soni SD; Johnson DA
    Br J Psychiatry; 1986 Sep; 149():386. PubMed ID: 2877707
    [No Abstract]   [Full Text] [Related]  

  • 37. Relationship between neuroleptic extrapyramidal syndromes and patients' all-cause mortality.
    Modestin J; Vogt Wehrli M; Stephan PL; Agarwalla P
    Pharmacopsychiatry; 2009 Mar; 42(2):57-60. PubMed ID: 19308879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cigarette smoking in schizophrenia: relationship to psychopathology and medication side effects.
    Goff DC; Henderson DC; Amico E
    Am J Psychiatry; 1992 Sep; 149(9):1189-94. PubMed ID: 1503131
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Extrapyramidal movement disorders arising during treatment of psychoses with drugs].
    Vatsek Ia
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1976; 76(3):453-7. PubMed ID: 4940
    [No Abstract]   [Full Text] [Related]  

  • 40. Medical and legal implications of side effects from neuroleptic drugs. A round-table discussion.
    Cancro R; Davis JM; Klawans H; Tancredi L
    J Clin Psychiatry; 1981 Feb; 42(2):78-82. PubMed ID: 6109720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.